Potential involvement of mi-RNA 574-3p in progression of prostate cancer: A bioinformatic study

被引:11
|
作者
Ashraf, Naeem M. [1 ]
Imran, Komal [1 ]
Kastner, David W. [2 ]
Ikram, Khadija [1 ]
Mushtaq, Ayesha [1 ]
Hussain, Aadil [1 ]
Zeeshan, Nadia [1 ]
机构
[1] Univ Gujrat, Dept Biochem & Biotechnol, Gujrat, Pakistan
[2] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA
关键词
Prostate cancer; miRNA; Extra-cellular vesicles; FANCONI-ANEMIA; PROTEIN; EXPRESSION; HYPOXIA; PATHWAY; TRANSCRIPTION; METASTASIS; MECHANISM; APOPTOSIS; PROMOTER;
D O I
10.1016/j.mcp.2017.07.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant gene expression is a hallmark of prostate cancer (PCa), the second deadliest disease affecting males worldwide. Dysregulation of miRNA has been associated with the progression of PCa and in recent studies, miRNA 574-3p was found to be upregulated in cancerous prostate tissue. In this study, we characterize the effects of upregulated miRNA 574-3p on gene expression in the tumor microenvironment through different bioinformatic tools such as Diana-Tools, the KEGG Pathway Database, and the Reactome Database. We have identified nine regulatory genes that are targeted by miRNA 574-3p and downregulated in prostate cells. Pathway analysis of these genes shows that they are involved in the regulation of the Notch signaling pathway, Wnt signaling pathway, apoptosis, DNA damage response, G1 to S cell-cycle control, inflammatory response pathway, angiogenesis, translation factors, and the expression of oncogenes. Our results show the oncogenic potential of miRNA 574-3p in PCa progression and metastasis. Moreover, this study highlights the complex molecular Mechanisms and pathways affected by the upregulation of miRNA 574-3p in prostate cells. In future studies, the presented data may aid in designing new therapies for PCa with improved efficacy. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [31] SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression
    Kawamura, Norihiko
    Nimura, Keisuke
    Saga, Kotaro
    Ishibashi, Airi
    Kitamura, Koji
    Nagano, Hiromichi
    Yoshikawa, Yusuke
    Ishida, Kyoso
    Nonomura, Norio
    Arisawa, Mitsuhiro
    Luo, Jun
    Kaneda, Yasufumi
    CANCER RESEARCH, 2019, 79 (20) : 5204 - 5217
  • [32] Circular RNA TUBA1C accelerates the progression of non-small-cell lung cancer by sponging miR-143-3p
    Yang, Jianru
    Jia, Yang
    Wang, Bing
    Yang, Shengrong
    Du, Kun
    Luo, Yujie
    Li, Yunhe
    Zhu, Bing
    CELLULAR SIGNALLING, 2020, 74
  • [33] Circulating plasma miR222-3P status and its potential diagnostic performance in prostate cancer
    Heydari, Zohreh
    Moudi, Emadoddin
    Sadeghi, Farzin
    Hajiahmadi, Mahmoud
    Rezatabar, Setareh
    Neamati, Nahid
    Parsian, Hadi
    JOURNAL OF GENE MEDICINE, 2022, 24 (12):
  • [34] RETRACTED: MiRNA-574-3p inhibits cell progression by directly targeting CCND2 in colorectal cancer (Retracted Article)
    Li, Wen-Cui
    Wu, Yan-Qiong
    Gao, Bo
    Wang, Chao-Yun
    Zhang, Juan-Juan
    BIOSCIENCE REPORTS, 2019, 39
  • [35] Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
    Kluth, Martina
    Volta, Heinke
    Hussein, Mohammad
    Taskin, Billurvan
    Frogh, Sohall
    Moeller-Koop, Christina
    Buescheck, Franziska
    Jacobsen, Frank
    Tsourlakis, Maria Christina
    Luebke, Andreas M.
    Hinsch, Andrea
    Clauditz, Till
    Graefen, Markus
    Heinzer, Hans
    Huland, Hartwig
    Minner, Sarah
    Sauter, Guido
    Wilczak, Waldemar
    Schlomm, Thorsten
    Simon, Ronald
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 5909 - 5917
  • [36] Loss of miR-516a-3p mediates upregulation of ABCCCC5 in prostate cancer and drives its progression
    Zhang, Hongtuan
    Lian, Zhenpeng
    Sun, Guangyu
    Liu, Ranlu
    Xu, Yong
    ONCOTARGETS AND THERAPY, 2018, 11 : 3853 - 3867
  • [37] Long non-coding RNA RNCR3 promotes prostate cancer progression through targeting miR-185-5p
    Tian, Chuang
    Deng, Yuanyuan
    Jin, Yong
    Shi, Songshan
    Bi, Hai
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (05): : 1562 - 1570
  • [38] miR-410-3p promotes prostate cancer progression via regulating PTEN/AKT/mTOR signaling pathway
    Zhang, Yuelong
    Zhang, Dahong
    Lv, Jia
    Wang, Shuai
    Zhang, Qi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (04) : 2459 - 2465
  • [39] Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1
    Long, Bo
    Li, Na
    Xu, Xi-Xia
    Li, Xiao-Xin
    Xu, Xin-Jie
    Liu, Jie-Ying
    Wu, Zhi-Hong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (02) : 561 - 568
  • [40] Long non-coding RNA LINC00173 serves as sponge for miR-338-3p to promote prostate cancer progression via regulating Rab25
    Hu, C-H
    Yang, X-J
    Yu, L.
    Wang, L-Y
    Zhao, X-C
    Han, C-H
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (18) : 9290 - 9302